-
公开(公告)号：KR1020130010100A
公开(公告)日：2013-01-25
申请号：KR1020110070610
申请日：2011-07-15
Applicant: 한림대학교 산학협력단
Abstract: PURPOSE: A composition containing an Acer barbinerve Max extract which suppresses cancer metastasis is provided to remarkably suppress cancer metastasis under cell apoptotic concentration. CONSTITUTION: An Acer barbinerve Max extract is prepared from Acer barbinerve Max barks using hot water and suppresses cancer metastasis. The extract is also prepared by extracting Acer barbinerve Max barks with hot water and fractioning with ethyl acetate. An anticancer agent contains the extract as an active ingredient. [Reference numerals] (AA) Bark; (BB) Lignum; (CC) Acer barbinerve Max(20ug/mL)
Abstract translation: 目的：提供抑制癌症转移的含有Acer barbinerve Max提取物的组合物，以显着抑制细胞凋亡浓度下的癌症转移。 构成：使用热水从Acer barbinerve Max barks制备Acer barbinerve Max提取物，抑制癌症转移。 提取物也是用热水提取Acer barbinerve Max树皮并用乙酸乙酯分级制备的。 抗癌剂含有提取物作为活性成分。 （附图标记）（AA）树皮; （BB）Lignum; （CC）Acer barbinerve Max（20ug / mL）
-
公开(公告)号：KR101174074B1
公开(公告)日：2012-08-14
申请号：KR1020100043080
申请日：2010-05-07
Applicant: 한림대학교 산학협력단
IPC: A61K36/484 , A61K31/352 , A61P35/00 , A23L1/30
Abstract: 감초의 유기 용매 추출물, 이의 분획물 및 이로부터 분리된 화합물의 항암 및/또는 암전이 억제에 있어서의 신규한 용도가 제공된다. 즉, 감초의 유기 용매 추출물, 이의 분획물 및 이로부터 분리된 화합물로 이루어진 군에서 선택된 1종 이상을 포함하는 항암 및/또는 암전이 억제용 조성물이 제공된다.
-
公开(公告)号：KR1020110077090A
公开(公告)日：2011-07-07
申请号：KR1020090133550
申请日：2009-12-30
Applicant: 한림대학교 산학협력단
CPC classification number: A61K36/75 , A23L33/105 , A23V2200/30 , A61K2236/33
Abstract: PURPOSE: An analgesic composition containing Ruta graveolens L. extract is provided to ensure excellent analgesic effects and to prevent side effects. CONSTITUTION: An analgesic composition contains Ruta graveolens L. extract as an active ingredient, isolated using water or alcohol of 1-4 carbon atoms. A food composition for treating pain contains the analgesic composition. A method for preparing the analgesic composition comprises: a step of preparing dried Ruta graveolens L.; a step of adding 5-20 time of water or alcohol of 1-4 carbon atoms to Ruta graveolens L.; and a step of isolating Ruta graveolens L. extract.
Abstract translation: 目的：提供含有Ruta graveolens L.提取物的止痛组合物，以确保极好的镇痛作用和预防副作用。 构成：镇痛组合物含有Ruta graveolens L.提取物作为活性成分，使用1-4个碳原子的水或醇分离。 用于治疗疼痛的食物组合物包含镇痛组合物。 制备镇痛组合物的方法包括：制备干燥的Ruta graveolens L.的步骤。 将5-20倍的1-4个碳原子的水或醇加入到茯苓中的步骤。 并分离Ruta graveolens L.提取物的一个步骤。
-
公开(公告)号：KR1020110077087A
公开(公告)日：2011-07-07
申请号：KR1020090133547
申请日：2009-12-30
Applicant: 한림대학교 산학협력단
IPC: A61K36/237 , A61P29/00
CPC classification number: A61K36/25 , A23L33/105 , A23V2200/30 , A61K2236/33
Abstract: PURPOSE: An analgesic composition containing Aralia cordata T. leaf extract is provided to prevent side effects of gastrointestinal disturgance, allergy, and hepatotoxicity. CONSTITUTION: An analgesic composition contains Aralia cordata T. leaf extract as an active ingredient, prepared using water or alcohol solvent of 1-4 carbon atoms. The Aralia cordata T. leaf extract is prepared by isolating with 10-95%(v/v) ethanol. A food composition for treating pain contains the analgesic composition. A method for manufacturing the analgesic composition comprises: a step of preparing dried Aralia cordata T. leaves; a step of isolating water and alcohol solvent of 1-4 carbon atoms; and a step of extracting at 50-100°C for 1-10 hours.
Abstract translation: 目的：提供含有Aralia cordata T.叶提取物的止痛组合物，以防止胃肠道痉挛，过敏和肝毒性的副作用。 构成：镇痛组合物含有Aralia cordata T.叶提取物作为活性成分，使用1-4个碳原子的水或醇溶剂制备。 通过用10-95％（v / v）乙醇分离来制备Aralia cordata T.叶提取物。 用于治疗疼痛的食物组合物包含镇痛组合物。 制备镇痛组合物的方法包括：制备干燥的Aralia cordata T.叶的步骤; 分离1-4个碳原子的水和醇溶剂的步骤; 和在50-100℃下提取1-10小时的步骤。
-
公开(公告)号：KR1020110050779A
公开(公告)日：2011-05-17
申请号：KR1020090107300
申请日：2009-11-09
Applicant: 한림대학교 산학협력단
IPC: B01D15/00 , G01N30/02 , A61K36/484 , A61P17/18
CPC classification number: B01D11/0492 , A61K36/484 , G01N30/6039 , G01N2030/027
Abstract: PURPOSE: A method for separating antioxidant material from licorice is provided to improve the efficiency of a dehyroglyasperin C, dehyroglyasperin D, and isoangustone A obtaining process from the licorice. CONSTITUTION: A fixed phase solvent is filled in the column of a high speed counter-current chromatography. A mobile phase solvent is injected into the column while the column is being rotated. When the fixed phase solvent is hydromechanically equivalent with the mobile phase solvent, licorice extract is injected through a sample injection hole in order to obtain effluent. Antioxidant materials are separated from the effluent.
Abstract translation: 目的：提供从甘草中分离抗氧化剂材料的方法，以提高甘草中脱氢胞苷C，脱氢丝氨酸D和异黄酮A获得过程的效率。 构成：在高速逆流色谱柱中填充固定相溶剂。 当柱旋转时，将流动相溶剂注入柱中。 当固定相溶剂与流动相溶剂在液力学上相当时，通过样品注入孔注入甘草提取物以获得流出物。 将抗氧化剂材料与流出物分离。
-
Patent Agency Ranking
公开(公告)号：KR1020110050343A
公开(公告)日：2011-05-13
申请号：KR1020100043080
申请日：2010-05-07
Applicant: 한림대학교 산학협력단
IPC: A61K36/484 , A61K31/352 , A61P35/00 , A23L1/30
CPC classification number: A61K36/484 , A23L29/035 , A23V2200/308 , A61K31/353 , A61K2236/33 , A61K2236/35
Abstract: PURPOSE: A composition containing an organic solvent extract of Glycyrrhiza uralensis fischer is provided to ensure anticancer or metastasis suppression. CONSTITUTION: A composition for suppressing cancer or metastasis contains an organic solvent extract of Glycyrrhiza uralensis fischer as an active ingredient. The organic solvent extract is isolated a mixture solvent of alkan of C5-C7 and alcohol of C1-C4.
Abstract translation: 目的：提供含有甘草甙的有机溶剂提取物的组合物，以确保抗癌或转移抑制。 构成：用于抑制癌症或转移的组合物含有甘草的有机溶剂提取物作为活性成分。 分离有机溶剂提取物，分离出C5-C7的烷烃和C1-C4的醇的混合溶剂。
-
公开(公告)号：KR1020110038381A
公开(公告)日：2011-04-14
申请号：KR1020090095650
申请日：2009-10-08
Applicant: 한림대학교 산학협력단
Abstract: PURPOSE: A composition containing Viola tricolor var. Hortensis extract for treating pain is provided to reduce or relieve pain without side effects. CONSTITUTION: An analgesic composition contains 0.1-99 weight% of crude extract of Viola tricolor var. Hortensis as an active ingredient. The extract is isolated using water or low alcohol of 1-4 carbon atoms. A food and pharmaceutical composition for preventing or treating pain contains 0.01-15 weight% of analgesic composition. The food and pharmaceutical composition is medicinal product, food, food additive, or beverage.
Abstract translation: 目的：含有中堇三色变种的组合物。 提供用于治疗疼痛的Hortensis提取物以减轻或缓解疼痛而没有副作用。 构成：镇痛组合物含有0.1-99重量％的中提琴三色变种的粗提物。 Hortensis作为活性成分。 使用1-4个碳原子的水或低级醇分离提取物。 用于预防或治疗疼痛的食品和药物组合物含有0.01-15重量％的止痛组合物。 食品和药物组合物是药用产品，食品，食品添加剂或饮料。
-
公开(公告)号：KR1020160066742A
公开(公告)日：2016-06-13
申请号：KR1020140171876
申请日：2014-12-03
Applicant: 한림대학교 산학협력단
IPC: A61K36/185 , A61P3/04 , A61P3/00
CPC classification number: A61K36/185 , A61J3/04 , A61K36/00 , A61K36/18 , Y10S514/885
Abstract: 때죽나무열매추출물과그 분획의지방축적억제효과를시험하였다. 때죽나무열매추출물과그 분획 (0~500 ㎍/㎖)에세포를 72시간동안노출시킨것은미처리대조군과비교하여세포생존율에는아무런영향을미치지않았다. 때죽나무열매추출물과그 분획은 50~300 ㎍/㎖농도에서투여량의존적으로 3T3-L1 지방세포의지방축적을저해하였다. 지방세포생성의주요마커들인 PPARγ및 C/EBPα발현은미처리대조군과비교할때 8일간세포에때죽나무열매추출물또는그 분획을처리한경우현저히감소하였다 (p
Abstract translation: 本发明涉及含有雪花果实提取物的用于预防或治疗肥胖症的组合物。 在用于测试雪花果实提取物及其部分对脂肪蓄积抑制作用的实验中，提取物及其部分降低活性氧的含量，并减少参与脂肪细胞产生的转录因子的数量，由此抑制 脂肪细胞生产。 这样的结果表明，提取物和级分可用作治疗剂作为天然抗肥胖物质或用于预防和改善肥胖症。
-
公开(公告)号：KR101447657B1
公开(公告)日：2014-10-07
申请号：KR1020130007792
申请日：2013-01-24
Applicant: 한림대학교 산학협력단
Abstract: 본 발명은 항암 조성물에 관한 것으로, 전나무(
Abies
holophylla
MAX ) 잎 에탄올 추출물을 유효성분으로 함유하는 항암 조성물 및 전나무(
Abies
holophylla
MAX ) 잎 에탄올 추출물을 디클로로메탄으로 분획하여 수득된 디클로로메탄 분획물을 유효성분으로 함유하는 항암 조성물을 제공한다.-
公开(公告)号：KR1020130010061A
公开(公告)日：2013-01-25
申请号：KR1020110070611
申请日：2011-07-15
Applicant: 한림대학교 산학협력단
Abstract: PURPOSE: A Populus timentiglandulosa T. Lee bark extract with an anti-inflammation activity and a composition containing the same are provided to ensure excellent anti-inflammatory activity under cell apoptotic concentration. CONSTITUTION: A Populus timentiglandulosa T. Lee bark extract with an anti-inflammatory activity is prepared by extracting Populus timentiglandulosa T. Lee barks using hot water. The extract is prepared by extracting Populus timentiglandulosa T. Lee barks using hot water and fractioning with ethyl acetate. A composition for anti-inflammation contains the extract as an active ingredient. [Reference numerals] (AA) Populus timentiglandulosa T. Lee(20ug/mL)
Abstract translation: 目的：提供具有抗炎活性的山杨（Tumiglanlanloslosa）李氏树皮提取物和含有其的组合物，以确保在细胞凋亡浓度下优异的抗炎活性。 构成：通过使用热水提取杨树杨树皮栗子制备具有抗炎活性的山杨（Tulusiglandulosa）李氏树皮提取物。 提取物是通过使用热水提取杨树杨树皮，并用乙酸乙酯分级制备的。 用于抗炎的组合物含有提取物作为活性成分。 （参考号）（AA）白杨木杨（Lee）（20ug / mL）
-
-
-
-
-
-
-
-
-
Search Results
38
records
(took 0.032 seconds)
